Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy

Paclitaxel (PTX) has shown pleiotropic immunologic effects on the tumor microenvironment, and nanomicelle has emerged as a promising strategy for PTX delivery. However, the detailed mechanisms remain to be fully elucidated. Meanwhile, immunogenic cell death (ICD) is an effective approach to activate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qianmei, Shi, Gang, Chen, Xiaolei, Lin, Yi, Cheng, Lin, Jiang, Qingyuan, Yan, Xi, Jiang, Ming, Li, Yiming, Zhang, Hantao, Wang, Huiling, Wang, Yuan, Wang, Qingnan, Zhang, Yujing, Liu, Yi, Su, Xiaolan, Dai, Lei, Tang, Minghai, Li, Jia, Zhang, Lan, Qian, Zhiyong, Yu, Dechao, Deng, Hongxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381738/
https://www.ncbi.nlm.nih.gov/pubmed/32724476
http://dx.doi.org/10.7150/thno.45391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381738/
https://www.ncbi.nlm.nih.gov/pubmed/32724476
http://dx.doi.org/10.7150/thno.45391

Ejemplares similares